MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Biomet vet Serbousek to succeed Mason as Orthofix CEO | Personnel Moves, August 13, 2019

Biomet vet Serbousek to succeed Mason as Orthofix CEO | Personnel Moves, August 13, 2019

By

Orthofix names Serbousek CEOOrthofix (NSDQ:OFIX) last week named a successor for president & CEO Brad Mason in November, tapping Jon Serbousek as president of its spine business effective August 5.

Mason is slated to retire Oct. 31; Serbousek, a 30-year medtech veteran with stints at Biomet, Medtronic (NYSE:MDT) and Johnson & Johnson (NYSE:JNJ) unit DePuy Orthopaedics, is due to take over the corner office the next day.

“Jon’s expertise and proven track record are perfectly aligned with our business composition and make him an exceptional choice to lead the company as President and CEO,” Mason said in prepared remarks. “With the recent leadership change in our spine business, I am pleased that Jon has agreed to serve as the president of global spine on an interim basis. This will give him time to focus on our needs and opportunities in that business before he takes on the broader CEO role, which should help ensure a seamless leadership transition for the benefit of all Orthofix stakeholders.”

“I am excited to join Orthofix,” Serbousek added. “It is an honor to assume this leadership role, particularly at a time when the company is so well positioned for future shareholder value creation. I look forward to working with the great team at Orthofix as we continue to shape the company for the years ahead.”

 Ra Medical ousts CEO Irwin
Ra Medical (NYSE:RMED) yesterday ousted chairman, CEO, co-president & CTO Dean Irwin without cause. The excimer laser system maker named CFO Andrew Jackson as interim CEO while it seeks a permanent replacement for Irwin. Martin Colombatto was named chairman.

“On behalf of the entire Ra Medical board, I want to thank Dean for his contributions and for his years of service to Ra Medical. The board is focused on finding a CEO who can guide us through the next phase of commercialization and growth,” Colombatto said.
Read More

 Corinth Medical taps Duddy for CEO
Fresh off of a $12 million funding round for its Velonion urology device, Corinth Medical today named Steven Duddy to replace founder Csaba Truckai as president & CEO.

“Steve brings an exemplary track record of executive skills combined with business vision gained through his global leadership in the medical device arena,” Truckai said in prepared remarks. “His success in developing go-to-market commercialization strategies will be invaluable to the company and make him an excellent fit for the position and the organization.”

“This is a very exciting time for Corinth MedTech and its Veloxion System, which has a strong intellectual property position and tremendous potential to improve patient health. I am honored to lead the company and look forward to the opportunity to build a powerful commercial brand,” Duddy added.
Read More

 CeloNova BioSciences names ex-Tryton chief St. Bernard as CEO
CeloNova BioSciences last week named former Tryton Medical chief executive Carl St. Bernard to be its new president & CEO.

St. Bernard replaces two-year interim chief Jason Cone, who was named to a seat on CeloNova’s board.
Read More

 Boudousquie takes the helm at Nimbus
Med Venture Holdings said it named former RadiaDyne president Bret Boudousquie as the new CEO of portfolio company Nimbus.
Read More

In case you missed it

RSS From Medical Design & Outsourcing

  • Medical device companies put $3.6 billion in docs’ pockets, study finds
    Medtech companies paid $3.62 billion for access to physicians — 10% more than drug companies did — from 2014 to 2017, according to new research. Device company payments to surgical specialists were significantly more tied to the surgeons’ Medicare billing than payments from drug companies to specialists, according to the study, which appears in the… […]
  • FDA slaps Class I label on rapid infuser recall
    The FDA today declared that the recall of an emergency infusion device kit is the most serious type. The recall covers three models of disposable sets made by Smisson-Cartledge Biomedical for its ThermaCor 1200 rapid infuser, which is used for fluid or bolus delivery. The system is made of a footswitch for hands-free fluid control,… […]
  • Cretex breaks ground on new plant north of Minneapolis
    Cretex Cos. last week broke ground on a new 245,000 ft2 medical device contract manufacturing plant in Brooklyn Park, Minn. Elk River, Minn.–based Cretex plans to complete facility construction by the end of the year. The company expects the facility by the end of 2022 to house its stamping, molding and tool design — and… […]
  • Resonetics to expand manufacturing in Costa Rica
    Resonetics announced today it has leased new manufacturing space in Costa Rica to more than double its production there. The space, in a building near its current site in the Coyol Free Zone business park in Alajuela, will be expanded and reconfigured to create a 45,000 ft² production site. The move comes after the company… […]
  • Are Black patients not getting LVADs as quickly as white patients?
    Researchers from the University of Missouri conducted a study that found disparities in treating Black and white patients with advanced heart failure. According to a news release, the study found that Black patients with advanced heart failure were more likely to receive a left ventricular assist device (LVAD) — a pump implanted into the chest… […]
  • Viant expands factory in Costa Rica
    Viant announced today that it has completed a major expansion of its medical device manufacturing facility in Heredia, Costa Rica. The company said it invested in the additional capacity to meet market demand for minimally invasive surgical devices, including energy-based devices. Begun in fall 2020, the expansion adds 14,000 ft² of ISO Class 8 cleanroom… […]
  • St. Jude Medical founder and his Medical 21 raise $3M
    Raising money for a startup company during a pandemic is no cakewalk, according to Manny Villafaña. But he did it. Medical 21, the latest venture for the founder of St. Jude Medical, has raised another $3 million in an equity offering, according to an SEC filing. The most recent round brings the Minneapolis-based startup’s total funding… […]
  • How can patient input improve clinical trials?
    The Medical Device Innovation Consortium (MDIC) has laid out some recommendations for improving medical device clinical trials with increased patient input. Having observed that clinical trial sponsors seldom refer to patient input — something the FDA issued guidance for in September 2019 — MDIC offered its view on increasing and using patient input to improve… […]
  • Orchid names new CFO
    Orchid Orthopedic Solutions (Holt, Mich.) announced this week that Matt Tharp has joined the company as chief financial officer. Tharp comes to Orchid from Ammega, where he held the role of CFO – Americas. He has more than 20 years of experience in supply chain, operations and finance and has held leadership roles at Midwest… […]
  • ICS establishes dedicated medical device practice
    Integrated Computer Solutions (ICS) is establishing a dedicated medical device practice amid increased demand for complex medtech. ICS said its work in the medical and life sciences markets has nearly doubled year-over-year as connected technologies drive innovation and transform healthcare. “There has been extraordinary innovation and growth in the medtech sector in recent years which… […]
  • SMC is expanding its Costa Rica facility
    SMC (Somerset, Wis.) recently announced that it will double the size of its Alajuela, Costa Rica facility to 120,000 ft2 this year. The additional space will enable SMC Costa Rica to provide increased contract manufacturing solutions, including assembly, injection molding and secondary operations. SMC plans to double the number of workers it has in the Central… […]